Biologics for rheumatoid arthritis
97 results
1 - 97
Biologic interventions for fatigue in rheumatoid arthritis
Biologics for rheumatoid arthritis - Biologics for people with rheumatoid arthritis naive to methotrexate
- Biologics for rheumatoid arthritis: an overview of Cochrane reviews
No increased risk of cancer with biologic therapy for rheumatoid arthritis- Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics
- Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis
- Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta‐analysis
- Methotrexate monotherapy versus methotrexate combination therapy with non‐biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis
- Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis: A network meta‐analysis
- Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis
- Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease‐modifying anti‐rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta‐analysis (NMA)
- Rheumatoid arthritis
- Abatacept for rheumatoid arthritis
- Biologicals improve outcomes in patients with RA
- Effects of glucocorticoids on radiological progression in rheumatoid arthritis
- Disease‐modifying anti‐rheumatic drugs for rheumatoid arthritis: a systematic review and network meta‐analysis
- Combination therapy in rheumatoid arthritis
- Tocilizumab for rheumatoid arthritis: Cochrane systematic review
- Golimumab for rheumatoid arthritis: Cochrane systematic review
- Anakinra for rheumatoid arthritis: Cochrane systematic review
- Juvenile idiopathic arthritis (juvenile rheumatoid arthritis)
- Effects of glucocorticoids on radiological progression in rheumatoid arthritis
- Etanercept for the treatment of rheumatoid arthritis: Cochrane systematic review
- Anakinra for rheumatoid arthritis
- Psoriatic arthritis
- Methotrexate for treating rheumatoid arthritis
- Adalimumab for treating rheumatoid arthritis
- Rituximab for rheumatoid arthritis: Cochrane systematic review
- Iritis (inflammation of the iris)
- Zoster vaccine not associated with increased risk of HZ infection in immune-mediated disease patients
- Updated ACR guideline on managing patients with rheumatoid arthritis
- Infections in immunosuppressed and cancer patients
- Abatacept for rheumatoid arthritis
- Leflunomide for the treatment of rheumatoid arthritis
- Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis): Cochrane systematic review
- Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
- Infliximab for the treatment of rheumatoid arthritis
- Tai Chi for rheumatoid arthritis
- Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity
- Antidepressants for pain management in rheumatoid arthritis: Cochrane systematic review
- Adverse effects of biologics: a network meta‐analysis and Cochrane overview
- Chronic diseases and pregnancy
- Tocilizumab for giant cell arteritis
- Methotrexate for induction of remission in refractory Crohn's disease: Cochrane systematic review
- COVID-19 and other coronavirus infections